Company Mar Pharma Veterinary Srl with Fiscal Code 14610424
recorded a turnover of 2024 of
84.830,
with a net profit of
57.681
and having an average number of employees of
1.
The company operates in the field of Închirierea şi subînchirierea bunurilor imobiliare proprii sau închiriate having the NACE code 6820.
Sales - Ron
Sales, Profit, Employees, Total Income, Financial Results -
Mar Pharma Veterinary Srl
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Sales - EUR
53.361
83.742
86.594
81.979
83.300
58.564
72.069
79.957
83.764
84.830
Total Income - EUR
53.361
83.742
86.821
81.979
83.300
58.564
72.069
79.961
83.764
84.830
Total Expenses - EUR
20.664
20.792
18.346
17.042
15.384
14.998
14.385
14.884
22.587
25.438
Gross Profit/Loss - EUR
32.697
62.950
68.475
64.937
67.916
43.566
57.684
65.077
61.177
59.393
Net Profit/Loss - EUR
31.097
60.438
65.870
62.478
65.417
41.839
55.566
63.141
60.339
57.681
Employees
0
2
1
0
0
0
0
0
1
1
The table presents the most important indicators of the company from the Profit and Loss Account for the last 10 years of activity as found at the Ministry of Finance. The data provides the evolution of the company during this period regarding the increases and possibly decreases recorded.
In the last year of activity, the sales increased by 1.8%, from 83.764 euro in the year 2023, to 84.830 euro in 2024.
The Net Profit decreased by -2.321 euro, from 60.339 euro in 2023, to 57.681 in the last year.
Check the financial reports for the company - Mar Pharma Veterinary Srl
Financial Rating - MAR PHARMA VETERINARY SRL
See the company's note based on the submitted financial data, relative to the industry of which it is a part.
Financial Rating
Payment Limits - Mar Pharma Veterinary Srl
See the company's payment capacity for situations in which you conclude contracts with payment terms.
Check Payment Limits
Prob. of insolvency - Mar Pharma Veterinary Srl
It determines the risk of insolvency based on the submitted accounting balance.
Insolvency Probability
Financial Reports - Mar Pharma Veterinary Srl
Check all the financial reports of the company and know the risks in collaboration with it.
Check Financial Reports
Financial Analysis Reports provide a clear and comprehensive view of a company's financial activity. In addition to presenting financial data, the reports analyze this data so that any user can understand whether the results are positive or less favorable. The Financial Rating provides an analysis based on the most important financial ratios, including liquidity, solvency, and profitability. Payment Limits represent the maximum amounts for which a company can offer goods or services on credit to its clients. The Probability of Insolvency presents the theoretical probability that a company may not be able to meet its financial obligations towards its creditors, i.e., suppliers and financial institutions.
Debts, Equity, Inventories, Receivables, Accounts, Assets -
Mar Pharma Veterinary Srl - CUI 14610424
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Fixed Assets
400.848
383.117
363.307
344.607
327.202
310.661
294.332
286.604
277.121
263.435
Current Assets
117.098
78.004
91.415
118.757
117.129
114.241
121.998
125.982
47.667
7.510
Inventories
0
0
0
0
0
0
0
0
0
0
Receivables
70.689
60.405
59.928
2.663
91.469
118
1.209
92.985
42.917
1.479
Cash
46.409
17.599
31.487
116.094
25.660
114.123
120.789
32.997
4.750
6.031
Shareholders Funds
509.508
288.413
289.988
282.482
281.161
317.670
366.191
270.743
267.312
263.497
Social Capital
45
45
44
43
42
41
40
41
40
40
Debts
8.437
172.708
164.072
180.882
163.170
107.231
50.139
141.843
57.476
7.448
Income in Advance
0
0
662
0
0
0
0
0
0
0
Exchange rate - RON
4.9743
4.9465
4.9315
4.9468
4.8371
4.7454
4.6535
4.5681
4.4908
4.445
Main CAEN
"6820 - 6820"
CAEN Financial Year
6820
The table presents the company's Balance Sheet structure for the last 10 years. Current Assets recorded a value of
7.510 euro in 2024 which includes Inventories of
0 euro, Receivables of
1.479 euro and cash availability of
6.031 euro.
The company's Equity was valued at
263.497 euro, while total Liabilities amounted to
7.448 euro.
Equity decreased by -2.321 euro, from 267.312 euro in 2023, to 263.497 in 2024.
Similar services useful for checking companies and business development.
SellNet
Get the contact details for any company and get in touch with it.
Sectoral Studies
Knows the market and develops its own development strategies according to sectorial data.
Databases
Export in excel files the data of the companies selected according to the desired criteria.
Import - Export
Find importers and exporters according to the type of activity and the countries in which they carry it out.
Similar services represent services associated with companies that allow for a better analysis of clients and suppliers. Company Contacts help you get in touch with the desired companies. Sector Studies provide an overview of an industry, the most important competitors, and the geographical distribution of companies. Company Lists allow you to attract new clients, while Import-Export services give you access to companies engaged in such activities.
Comments - Mar Pharma Veterinary Srl